Advances in the Early Detection of Anthracycline-associated Cardiotoxicity
10.3870/j.issn.1672-0741.24.11.005
- VernacularTitle:蒽环类药物心脏毒性早期检测研究进展
- Author:
Min DAN
1
;
Yongsheng JIANG
1
Author Information
1. 华中科技大学同济医学院附属同济医院肿瘤科,武汉 430030
- Publication Type:Journal Article
- Keywords:
anthracycline;
cardiotoxicity;
early detection
- From:
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
2025;54(2):267-274
- CountryChina
- Language:Chinese
-
Abstract:
Anthracyclines(ANT),serving as a broad-spectrum antitumor medication,play a pivotal role in the treatment of various malignant tumors such as breast cancer,lymphoma,and soft tissue tumors.Nevertheless,their profound cardiotoxicity not only imposes limitations on the clinical application of these drugs,but also has significant impacts on patients'quality of life and long-term prognosis.In recent years,with the continuous advancement of detection technology,methods for detecting an-thracycline-induced cardiotoxicity have been constantly updated and developed.This review mainly aims to provide crucial in-sights into current methods for detecting anthracycline-induced cardiotoxicity in order to facilitate early detection and clinical management while reducing the risk of severe cardiac injury in cancer patients.
